TRIM for Tissue Specificity
- PMID: 38229746
- PMCID: PMC10788936
- DOI: 10.1021/acsmedchemlett.3c00504
TRIM for Tissue Specificity
Abstract
Tissue-specific manipulation of proteins is a long-standing objective in the field of targeted protein degradation, but still a distant prospect. Currently, the most successfully employed E3 ubiquitin ligases belong to the most ubiquitously expressed representatives. Unlocking of the TRIM58 ligase might represent a promising step toward tissue-specific PROTACs and molecular glue degraders.
© 2023 The Author. Published by American Chemical Society.
Conflict of interest statement
The author declares no competing financial interest.
References
-
- Hoegenauer K.; An S.; Axford J.; Benander C.; Bergsdorf C.; Botsch J.; Chau S.; Fernández C.; Gleim S.; Hassiepen U.; Hunziker J.; Joly E.; Keller A.; Lopez Romero S.; Maher R.; Mangold A.-S.; Mickanin C.; Mihalic M.; Neuner P.; Patterson A.; Perruccio F.; Roggo S.; Scesa J.; Schroeder M.; Shkoza D.; Thai B.; Vulpetti A.; Renatus M.; Reece-Hoyes J. Discovery of ligands for TRIM58, a novel tissue selective E3 ligase. ACS Med Chem Lett 2023, 14, 1631.10.1021/acsmedchemlett.3c00259. - DOI - PMC - PubMed
-
- Thom C. S.; Traxler E. A.; Khandros E.; Nickas J. M.; Zhou O. Y.; Lazarus J. E.; Silva A. P. G.; Prabhu D.; Yao Y.; Aribeana C.; Fuchs S. Y.; Mackay J. P.; Holzbaur E. L. F.; Weiss M. J. Trim58 Degrades Dynein and Regulates Terminal Erythropoiesis. Dev Cell 2014, 30 (6), 688–700. 10.1016/j.devcel.2014.07.021. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
